Total Payments
$537.95
2024 Payments
$321.79
Companies
8
Transactions
13
Medicare Patients
11,171
Medicare Billing
$3.2M
Payment Breakdown by Category
Food & Beverage$537.95 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $537.95 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Harrow Eye, LLC | $248.06 | 2 | $0 (2024) |
| Spark Therapeutics, Inc. | $84.78 | 1 | $0 (2019) |
| ABBVIE INC. | $55.04 | 3 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $54.96 | 2 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $31.20 | 2 | $0 (2024) |
| Alcon Vision LLC | $23.90 | 1 | $0 (2019) |
| ThromboGenics, Inc. | $22.58 | 1 | $0 (2018) |
| Bausch & Lomb Americas Inc. | $17.43 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $321.79 | 5 | Harrow Eye, LLC ($248.06) |
| 2023 | $33.13 | 2 | Bausch & Lomb Americas Inc. ($17.43) |
| 2022 | $37.19 | 2 | Regeneron Healthcare Solutions, Inc. ($19.51) |
| 2021 | $14.58 | 1 | AbbVie Inc. ($14.58) |
| 2019 | $108.68 | 2 | Spark Therapeutics, Inc. ($84.78) |
| 2018 | $22.58 | 1 | ThromboGenics, Inc. ($22.58) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Harrow Eye, LLC | IHEEZO (Drug) | Food and Beverage | In-kind items and services | $123.06 | General |
| Category: OPTOMETRY | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $35.45 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/18/2024 | Harrow Eye, LLC | IHEEZO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: OPTOMETRY | ||||||
| 09/11/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: EYE CARE | ||||||
| 03/14/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Ophthalmology | ||||||
| 12/08/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $15.70 | General |
| Category: Ophthalmology | ||||||
| 02/20/2023 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Ophthalmology | ||||||
| 09/09/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/28/2022 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: RETINA | ||||||
| 04/28/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2019 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Food and Beverage | In-kind items and services | $84.78 | General |
| Category: OCULAR | ||||||
| 07/01/2019 | Alcon Vision LLC | ORA (Device) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Ophthalmology | ||||||
| 09/21/2018 | ThromboGenics, Inc. | Jetrea (Drug) | Food and Beverage | Cash or cash equivalent | $22.58 | General |
| Category: Opthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 2,820 | 8,097 | $2.7M | $1.0M |
| 2022 | 18 | 2,980 | 6,143 | $2.0M | $653,588 |
| 2021 | 22 | 2,908 | 6,846 | $2.6M | $1.0M |
| 2020 | 16 | 2,463 | 5,230 | $1.7M | $571,538 |
Total Patients
11,171
Total Services
26,316
Medicare Billing
$3.2M
Procedure Codes
70
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 68 | 796 | $780,000 | $536,220 | 68.7% |
| 67028 | Injection of drug into eye | Office | 2023 | 382 | 2,313 | $1.2M | $177,483 | 15.3% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 347 | 1,907 | $190,700 | $101,319 | 53.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 551 | 701 | $122,675 | $57,414 | 46.8% |
| 92134 | Imaging of retina | Office | 2023 | 568 | 1,344 | $134,400 | $38,520 | 28.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 200 | 200 | $52,000 | $22,333 | 42.9% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2023 | 42 | 86 | $94,600 | $20,560 | 21.7% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2023 | 20 | 21 | $63,000 | $18,191 | 28.9% |
| 92250 | Photography of the retina | Office | 2023 | 348 | 354 | $53,100 | $9,195 | 17.3% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 29 | 42 | $50,400 | $6,798 | 13.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 85 | 109 | $13,625 | $6,119 | 44.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $4,950 | $2,713 | 54.8% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 115 | 152 | $8,360 | $2,555 | 30.6% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 47 | 54 | $13,500 | $1,806 | 13.4% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 37 | 344 | $336,000 | $241,345 | 71.8% |
| 67028 | Injection of drug into eye | Office | 2022 | 405 | 1,856 | $928,000 | $143,976 | 15.5% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 351 | 1,316 | $131,600 | $70,440 | 53.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 550 | 649 | $113,575 | $56,559 | 49.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 196 | 196 | $50,960 | $22,394 | 43.9% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2022 | 49 | 87 | $95,700 | $20,497 | 21.4% |
| J3590 | Unclassified biologics | Office | 2022 | 202 | 367 | $36,700 | $20,411 | 55.6% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2022 | 19 | 19 | $57,000 | $16,751 | 29.4% |
| 92134 | Imaging of retina | Office | 2022 | 445 | 505 | $50,500 | $14,604 | 28.9% |
| 67113 | Complex repair of detached retina and drainage of eye fluid between lens and retina | Facility | 2022 | 12 | 12 | $40,800 | $12,011 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 155 | 194 | $24,250 | $11,112 | 45.8% |
About Dr. Robert Lee, MD
Dr. Robert Lee, MD is a Retina Specialist healthcare provider based in South Bend, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1962401869.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Lee, MD has received a total of $537.95 in payments from pharmaceutical and medical device companies, with $321.79 received in 2024. These payments were reported across 13 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($537.95).
As a Medicare-enrolled provider, Lee has provided services to 11,171 Medicare beneficiaries, totaling 26,316 services with total Medicare billing of $3.2M. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Ad
Practice Information
- Specialty Retina Specialist
- Other Specialties Ophthalmology
- Location South Bend, IN
- Active Since 07/21/2005
- Last Updated 07/12/2017
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1962401869
Products in Payments
- IHEEZO (Drug) $248.06
- LUXTURNA (Biological) $84.78
- OZURDEX (Drug) $40.46
- EYLEA HD (Biological) $35.45
- Syfovre (Drug) $31.20
- ORA (Device) $23.90
- Jetrea (Drug) $22.58
- EYLEA (Biological) $19.51
- XIPERE (Drug) $17.43
- VRAYLAR (Drug) $14.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.